v3.24.2.u1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 3,563 $ 859 $ 6,378 $ 1,633
General and administrative 1,506 362 3,434 843
Total operating expenses 5,069 1,221 9,812 2,476
Loss from operations (5,069) (1,221) (9,812) (2,476)
Other income (expense):        
Interest income 98 0 238 0
Interest expense 0 (222) 0 (304)
Loss on debt extinguishment 0 (2,262) 0 (2,262)
Other income 0 4 0 5
Net loss (4,971) (3,701) (9,574) (5,037)
Preferred stock deemed dividend 0 (1,324) 0 (1,324)
Net loss attributable to common stockholders $ (4,971) $ (5,025) $ (9,574) $ (6,361)
Loss per share, basic (in dollars per share) $ (0.36) $ (1.43) $ (0.70) $ (1.84)
Loss per share, diluted (in dollars per share) $ (0.36) $ (1.43) $ (0.70) $ (1.84)
Weighted average number of shares of common stock, basic (in shares) 13,712,152 3,516,579 13,710,819 3,463,635
Weighted average number of shares of common stock, diluted (in shares) 13,712,152 3,516,579 13,710,819 3,463,635

Source